期刊文献+

医事犯罪中的因果关系判断——以疾病进程为考察要点

Judgment of Causal Relationship in the Medical Crime——From Disease Process
下载PDF
导出
摘要 医事犯罪中的因果关系基本遵循条件说。但是,基于医疗技术的特殊性,在判断因果关系成立与否时,需要从循证医学的角度,明晰疾病进程这一因素的重要性。具体来说,需要考察疾病的进程是否进入不可逆期,了解疾病有无公认的积极治疗方式,明确客观上是否不能实施治疗行为,确证治疗与否或者不同时期的治疗对于疾病的伤亡几率降低有没有显著性差异。 .Causal relationship judgment of Medical Crime follows condition theory. However, based on the particularity of medical technology, the importance of disease process should be clarified when judging causation relationship from the point of view of evidence-based medicine. Whether the disease has evolved into irreversible stage should be reviewed and the widely accept- ed. Active treatment of the disease should be explored so as to ensure that no treatment could be done. Moreover, whether the difference between treatment and non-treatment, and the difference among treatments of different period significantly reduce causalities.
作者 饶璟 叶睿 RAO Jing YE Rui(Civil Aviation Flight University of China, Guanghan, Sichuan 618307 Research Institute of Law, Sichuan Academy of Social Sciences, Chengdu, Sichuan 610071,China)
出处 《四川师范大学学报(社会科学版)》 CSSCI 北大核心 2017年第4期49-55,共7页 Journal of Sichuan Normal University(Social Sciences Edition)
基金 国家社会科学基金项目"刑罚模式对犯罪界域的制约关系研究"(11BFX113)之研究成果
关键词 医事犯罪 因果关系 疾病进程 循证医学 medical crime causal relationship the disease process evidence-based medicine
  • 相关文献

参考文献7

二级参考文献99

  • 1陈克正,刘绍基.新生儿红细胞增多症部分换血方法比较[J].中国新生儿科杂志,1992,17(4):153-155. 被引量:13
  • 2刘金榜,闫伟,高红梅.潜隐起病的肌萎缩侧索硬化症误诊2例分析[J].中国误诊学杂志,2004,4(10):1698-1699. 被引量:1
  • 3刘向乐.新生儿高粘血症及其对智能发育的影响[J].国外医学(妇幼保健分册),1994,5(2):63-65. 被引量:1
  • 4李洪义,孟舒,陈争,李海飞,杜敏联,马华梅,魏海云,段红蕾,郑辉,闻人庆,宋新明.Molecular Genetic Diagnostics of Prader-Willi Syndrome:a Validation of Linkage Analysis for the Chinese Population[J].Journal of Genetics and Genomics,2007,34(10):885-891. 被引量:1
  • 5KIMKO HC, REELE SS, HOLFORD NH, et ol. Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model[J]. Clin Pharmacol Ther, 2000, 68(5): 568-577.
  • 6MOULD DR. Developing models of disease progression[M]/ZENE IE, PAUL JW. Pharmacometrics: the science of quantitative pharmacology. Hoboken: John Wiley & Sons. Inc. 2007: 547- 576.
  • 7HOLFORD NH, PEACE KE. Methodologic aspects of a population pharmacodynamic modelA|zheimer patients treated with tacrine[J]. Proc Natl Acad Sci U S A, 1992, 89(23): 11466-11470.
  • 8ITO K, AHADIEH S, CORRIGAN B, et ol. Disease progression meta-analysis model in Alzheimer's disease[J]. Alzheimers Dement, 2010, 6(1): 39-53.
  • 9HOLFORD NH, CHAN PL, NUTT JG, et aL Disease progression and pharmacodynamies in Parkinson disease- evidence for functional proteetion with levodopa and other treatments[J]. J Pharmacokinet Pharmacodyn, 2006, 33 (3): 281-311.
  • 10PORS NIELSEN S, BARENHOLDT O, HERMANSEN F, et al. Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment [J]. Br J Obstet Gynaeeol, 1994, 101(4) : 319-324.

共引文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部